Measurements of its thickness are widely assessed in Alzheimer's disease, as it is one of the first regions to be impacted by the disease process (Braak & Braak, 1991) and researchers have found associations between its thickness and markers of amyloid and tau (Thaker et al., 2017). Here, MAPT is linked to Alzheimer disease.